2008
Epidemiological factors influencing IVF outcome: Evidence from the Yale IVF program
Matalliotakis I, Cakmak H, Arici A, Goumenou A, Fragouli Y, Sakkas D. Epidemiological factors influencing IVF outcome: Evidence from the Yale IVF program. Journal Of Obstetrics And Gynaecology 2008, 28: 204-208. PMID: 18393021, DOI: 10.1080/01443610801912436.Peer-Reviewed Original ResearchConceptsIVF outcomesFamily historyEpidemiological factorsIVF-ET cyclesIVF-ET outcomeIVF-ET treatmentNon-pregnant womenMain outcome measuresMedical School HospitalDegree of smokingAge of womenIVF-ETInfertile womenMenstrual statusObstetric historyPregnant womenRetrospective studyIVF programMedical filesFertilization outcomeMedical historyInverse associationIVF unitMenstrual symptomsOutcome measures
2005
Comparison of In Vitro Fertilization (IVF) Outcomes in Patients Treated with Highly Purified Urinary Follicle Stimulating Hormone (HP-Ufsh) Plus Human Menopausal Gonadotropins (hMG) or Follitropin α (r-hFSH) Plus hMG
Sakkas D, Anderson W, Arici A. Comparison of In Vitro Fertilization (IVF) Outcomes in Patients Treated with Highly Purified Urinary Follicle Stimulating Hormone (HP-Ufsh) Plus Human Menopausal Gonadotropins (hMG) or Follitropin α (r-hFSH) Plus hMG. Fertility And Sterility 2005, 83: s15-s16. DOI: 10.1016/j.fertnstert.2005.01.032.Peer-Reviewed Original Research
2001
Endometriosis and assisted reproductive technologies: are outcomes affected?
Mahutte N, Arici A. Endometriosis and assisted reproductive technologies: are outcomes affected? Current Opinion In Obstetrics & Gynecology 2001, 13: 275-279. PMID: 11396650, DOI: 10.1097/00001703-200106000-00005.Peer-Reviewed Original Research